Category: <span>Mesothelioma News</span>

Concordia Healthcare Announces Third Quarter Results – Revenue up…

All future quarterly dividends will be subject to quarterly financial review and board approval. , the Company announced that its subsidiary Pinnacle Biologics, Inc. enrolled the first group of patients in a randomized Phase 2 trial to evaluate photody…

Immunotherapy brings new treatment options to mesothelioma patients

Named breakthrough of the year by Science Magazine in 2013, immunotherapy is a new option for treating cancer, but not without speculation and concern. This new treatment is limited to a few types of cancers, but the remarkable results found from clinical trial data shows promise for the future. Immunotherapy uses the body to battle […]

15-Year Asbestos Saga in Libby Provokes Governor to Send Letter to EPA

After Libby Residents Wait 15 Years for Toxicity Test Results, Montana Governor Sends Letter to EPA

Asbestos victims and their families urged to claim compensation as DWP sets up fund

People who have contracted a form of cancer after working with asbestos are being urged to claim their share of a compensation pot. The Mesothelioma Fund was set up by the Department for Work and Pensions in April and is funded with insurer’s cash.

Asbestos ‘a danger to all hospital workers’, cancer sufferer warns

The former secretary at a leading metropolitan hospital has warned that asbestos is a danger to all hospital workers across the country, not just construction and maintenance staff. Russell Mills, who has worked in an office most of his life as an admi…

Printed NCCN Guidelines for Patients(R) Now Available Through Amazon.com

The National Comprehensive Cancer Network , with the support of the NCCN Foundation , announces the availability of printed versions of the NCCN Guidelines for Patients for order on Amazon.com for the following cancer types: Breast , Colon, and Pancrea…

Five Prime Therapeutics Announces Third Quarter 2014 Financial Results

Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided a corporate update and reported financial results for the third…

EnGeneIC and Asbestos Diseases Research Institute Initiate MesomiR-1…

Exploratory Study is First to Evaluate Novel microRNA Replacement Therapy for the Treatment of Malignant Pleural Mesothelioma First Clinical Trial Evaluating EDV” Nanocells Packaged with microRNAs /PRNewswire/ — EnGeneIC, Ltd. , an emerging biopharmac…

State Issues 19 Violations to 2 Companies for Demolition Project

Asbestos Violations Cost Scheming Construction Companies Nearly $380,000